Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $13 Million - $15.3 Million
24,500 Added 10.4%
260,100 $161 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $59.1 Million - $65.4 Million
-109,200 Reduced 31.67%
235,600 $130 Million
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $33.9 Million - $38.4 Million
64,100 Added 22.84%
344,800 $200 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $25.2 Million - $31.1 Million
-58,300 Reduced 17.2%
280,700 $149 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $39.6 Million - $45.7 Million
-79,500 Reduced 19.0%
339,000 $172 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $32 Million - $37.2 Million
63,000 Added 17.72%
418,500 $218 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $33 Million - $37.3 Million
-61,700 Reduced 14.79%
355,500 $205 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $15.9 Million - $18.7 Million
-32,700 Reduced 7.27%
417,200 $230 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $25.2 Million - $30 Million
49,700 Added 12.42%
449,900 $228 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.